Organon & Co | OGN - PE Price to Earnings


Organon & Co reported 8.32 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Merck 32.26 15.74 Jun/2026
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Novartis 21.36 3.57 Mar/2026
Organigram Holdings 12.01 222.99 Mar/2026
Organon & Co 8.32 4.57 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 16.35 2.78 Jun/2026
Qiagen NV 19.48 1.06 Mar/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Zealand Pharma A/S 3.27 1.86 Mar/2026